Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease

Published:2013-03-24 Issue:8 Volume:33 Page:1203-1210
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Chen Fei W.¹,Coyle Luke²³,Jones Brett E.¹³,Pattullo Venessa¹⁴³

Affiliation:

1. Department of Gastroenterology; Royal North Shore Hospital; Sydney Australia

2. Department of Haematology; Royal North Shore Hospital; Sydney Australia

3. Sydney Medical School; University of Sydney; Sydney Australia

4. Department of Gastroenterology; Concord Repatriation and General Hospital; Sydney Australia

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12154/fullpdf

Reference24 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepatitis,2004

2. Hepatitis B virus infection-natural history and clinical consequences;Ganem;N Engl J Med,2004

3. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer;Borentain;J Viral Hepatitis,2010

4. Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy;Kusumoto;J Gastroenterol,2011

5. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy;Yeo;Hepatology,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment;World Journal of Virology;2022-09-25

2. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

3. Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases;Journal of Clinical Medicine;2021-11-08

4. Renal infections in cancer patients;Onco-Nephrology;2020

5. Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study;PeerJ;2019-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3